Although exercise testing was not required to confirm the absence of symptoms, the low median NT-proBNP concentration of the cohort supports its early stage, particularly considering the advanced median age of the population and the presence of baseline AF and chronic kidney disease in a non-negligible number of subjects. The gene discussed is NPPB; the disease is atrial fibrillation.